FY2021 SEC EDGAR DEF 14A

Endo International plc CEO pay ratio

The CEO earned $29.0M in FY2021 against median worker pay of $65,759 · Chemicals & Pharmaceuticals.

State
L2
Filing date
2022-04-28
Industry
Chemicals & Pharmaceuticals
Fiscal year
FY2021

Data updated August 2026

Subscribe to Endo International plc CEO pay filing updates (RSS)

CEO-to-worker pay ratio
441:1
Extreme (Scale: 0–1000:1)
CEO pay
$29.0M
Median worker
$65,759

Latest filing FY2021. This company's newest DEF 14A on file is for FY2021, not FY2025, so the figures on this page are from that earlier year and are not ranked against the FY2025 industry benchmark. Industry pages mark issuers like this one with a "Latest filing" label.

Answer first

Endo International plc reported a 441:1 CEO-to-worker pay ratio in FY2021 - above the Chemicals & Pharmaceuticals median of 42:1 across 168 filers.

Figures come from Section 953(b) Dodd-Frank DEF 14A disclosures - not estimates. View all Chemicals & Pharmaceuticals companies.

Pay ratio
441:1
FY2021 disclosed
CEO total
$29.0M
Summary Compensation Table total
Median worker
$65,759
Dodd-Frank median employee

Ratio bands among Chemicals & Pharmaceuticals peers

Exclusive CEO-to-median-worker bands across 153 complete latest-FY filings in SIC 28. Segments sum to the peer set, not this company's compensation pillar.

CEO Compensation Breakdown, FY2021

A component-level pay breakdown is not reported in Endo International plc's structured SEC pay-ratio disclosure. See our methodology →

Industry Comparison - Chemicals & Pharmaceuticals

This Company's Ratio
441:1
Industry Median Ratio
42:1
Industry Median CEO Pay
$7.9M
This CEO's Pay
$29.0M
Companies in Industry
168
vs. Industry Median
Above

Endo International plc: HIGH · PEAK pay ratio

Endo International plc disclosed 441:1 CEO-to-worker pay and $29.0M CEO total in FY2021. the CEO earned 441× the median employee ($65,759) in FY2021.

Median employee $65,759 (PAR-MED); HIGH · PEAK stamps put about 441 median-wage years per CEO year.

CEO Total Pay

$29.0M

FY2021 Summary Compensation, well above median

Pay Ratio

441:1

Outlier, top decile

What FY2021 shows for Endo International plc

Endo International plc disclosed 441:1 CEO-to-worker pay and $29.0M CEO total in FY2021. The structured pay-ratio disclosure reports the total without line-item components. Chemicals & Pharmaceuticals (SIC 28) median ratio is 42:1 across 168 FY2025 filers; Endo International plc's $29.0M CEO total is above the $7.9M industry median CEO pay.

Endo International plc stamps HIGH · PEAK · PAR-MED; grant-date fair value (not realized pay) is what the DEF 14A reports. Open Chemicals & Pharmaceuticals peers.

Key Data, FY2021

Total Compensation
$29.0M
Median Employee Pay
$65,759
Pay Ratio
441:1
Filing Date
2022-04-28

Company Info

CIK
1593034
Industry
Chemicals & Pharmaceuticals
SIC Code
2834
State
L2
SEC EDGAR DEF 14A for CIK 1593034, FY2021. Informational only, not investment advice. Verify on EDGAR.

Read with Endo International plc

ABS(ceo_total_comp) peers first, then a SIC pole and a stamp-branched guide - not a fixed Related strip. This page stamps HIGH · PEAK · PAR-MED.

Data sourced from SEC EDGAR DEF 14A for Endo International plc (CIK 1593034), FY2021. See our methodology. Aggregated by PlainCEOPay as of August 2026.

Data currency: Executive compensation from SEC EDGAR DEF 14A proxy statements through fiscal year 2025, compiled and last refreshed August 2026. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.